After a rough start to the year, small- and mid-cap software stocks may be finding their footing. Goldman Sachs analyst Adam ...

Vertex Pharmaceuticals has solid revenue projections for its CF franchise, and a promising drug pipeline, especially in pain.

Vertex Rail Technologies opened in Wilmington in 2014 with promises of over 1,300 jobs and a $60 million investment. Despite initial optimism and orders, the company faced setbacks including ...

Vertex Pharmaceuticals is pressing pause on a phase 1/2 cystic fibrosis (CF) trial over a tolerability issue while reporting a separate impairment charge of $379 million tied to an earlier ...

By Christy Santhosh (Reuters) -Vertex Pharmaceuticals missed Wall Street estimates for quarterly results on Monday due to lower-than-expected sales of its cystic fibrosis (CF) drug Trikafta ...

Vertex Pharmaceuticals (NASDAQ:VRTX) missed on the top and bottom lines in its Q1 financial results and also raised the low end of its full-year total revenue range.The drugmaker best known for ...

Unrestricted Cash and Cash Equivalents: Over $270.4 million. Vertex Inc (NASDAQ:VERX) reported a strong start to 2025 with a 12.9% year-over-year increase in revenue, reaching $177.1 million.

Vertex Minerals chair Roger Jackson says he is confident the explorer is on the cusp of significant cash generation, as it moves toward production at its Hill End gold project in NSW. “This capital ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

NEW YORK (AP) — Carlos Rodón pitched six innings of two-hit ball for his fifth straight win, Aaron Judge went 0 for 3 to fall under .400 for the first time in more than a month and the surging ...

But who are the panellists for this week? Blankety Blank will be back with a brand new episode tonight and there are plenty of famous faces set to appear. The revived show continues to go from ...